📰 Exploratory Analysis News
Page 2 - Exploratory Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exploratory Analysis. Real-time updates on events, politics, business and more.
November 8, 2022
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence...
October 11, 2022
Those with smiling depression hide their true feelings & appear to act normally. Find out the signs, symptoms & risks to seek treatment 2023.
September 2, 2022
Pivotal results for efficacy and safety of Cosentyx (secukinumab) in hidradenitis suppurativa from Phase III SUNSHINE and SUNRISE trials to be debuted as late-breaker at European Academy of Dermatology
May 10, 2022
10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology ...
April 22, 2022
Data Include Exploratory Analysis Showing LIVTENCITY Treated Patients With Post-Transplant Cytomegalovirus (CMV) Infections/Disease Had Reductions in Hospitalizations (34.8%; p=0.021) and Length
January 18, 2022
Genome sequencing analysis dissects the origins and evolution of cancer transmission between clam species in the Seas of Southern Europe.
November 3, 2021
Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...
August 10, 2021
GuruFocus Article or News written by Marketwired and the topic is about:
February 23, 2021
Stocks plunge amid fears of second wave Premium Share Via Read Full Story Fears of a second wave of covid-19 infections and a likely surge in inflation from higher crude prices dragged Indian stocks by the most in two months on Monday, in tandem with falling equities and rising bond yields worldwide. The BSE Sensex fell 1,145.44 points or 2.25% to close at 49,744.32, while the broader Nifty index lost 306.05 points or 2.04% to close at 14,675.70. Indian indices are now 5% below their record hig...
February 22, 2021
The total tally of covid-19 cases on Monday crossed 1.10 crores and the toll reached close to 1,56,500.On Sunday alone, the country recorded 14,199 cases.